Research, on the other hand, lacks a clear explanation for the reduction of endogenous IL-22 serum or hepatic levels seen in male mice upon diet-induced MASLD or obesity challenge. Here, IL22 is linked to metabolic dysfunction-associated steatotic liver disease.